Aurinia Pharmaceuticals I... (AUPH)
NASDAQ: AUPH
· Real-Time Price · USD
8.09
0.10 (1.25%)
At close: Jun 05, 2025, 3:59 PM
8.15
0.80%
After-hours: Jun 05, 2025, 07:05 PM EDT
1.25% (1D)
Bid | 7.49 |
Market Cap | 1.09B |
Revenue (ttm) | 247.29M |
Net Income (ttm) | 39.84M |
EPS (ttm) | 0.27 |
PE Ratio (ttm) | 29.94 |
Forward PE | 10.52 |
Analyst | Buy |
Ask | 8.25 |
Volume | 937,305 |
Avg. Volume (20D) | 1,302,641 |
Open | 7.93 |
Previous Close | 7.99 |
Day's Range | 7.91 - 8.14 |
52-Week Range | 5.15 - 10.67 |
Beta | 1.16 |
About AUPH
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AUPH
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AUPH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
+10.9%
Aurinia Pharmaceuticals shares are trading higher ...
Unlock content with
Pro Subscription
8 months ago
+0.77%
Aurinia Pharmaceuticals shares are trading higher after the company announced a board restructuring consisting of seven members.

3 weeks ago · seekingalpha.com
Aurinia Pharmaceuticals Inc. (AUPH) Q1 2025 Earnings Call TranscriptAurinia Pharmaceuticals Inc. (NASDAQ:AUPH ) Q1 2025 Earnings Conference Call May 12, 2025 8:30 AM ET Company Participants Andrea Christopher - Corporate Communications and IR Peter Greenleaf - Preside...